Skip to product information
1 of 1

Shulph Ink

Neonatal Malignant Disorders, An Issue of Clinics in Perinatology

Neonatal Malignant Disorders, An Issue of Clinics in Perinatology

Regular price £67.48 GBP
Regular price £73.99 GBP Sale price £67.48 GBP
Sale Sold out
Tax included. Shipping calculated at checkout.
  • Condition: Brand new
  • UK Delivery times: Usually arrives within 2 - 3 working days
  • UK Shipping: Fee starts at £2.39. Subject to product weight & dimension
Trustpilot 4.5 stars rating  Excellent
We're rated excellent on Trustpilot.
  • More about Neonatal Malignant Disorders, An Issue of Clinics in Perinatology

A collection of articles by expert authors on the diagnosis and treatment of neonatal malignant disorders, including genetic predisposition, infant leukemias, brain tumors, retinoblastoma, kidney tumors, liver tumors, neuroblastoma, sarcoma, germ cell tumors, neonatal histiocytoses, lymphatic malformations, and long-term outcomes in neonatal cancer survivors.

Format: Hardback
Length: 240 pages
Publication date: 28 March 2021
Publisher: Elsevier - Health Sciences Division


Expert Insights on Neonatal Malignant Disorders


In a collaborative effort with Consulting Editor, Dr. Lucky Jain, Guest Editor Dr. Daniel Wechsler has brought together a team of esteemed expert authors to deliver a comprehensive and up-to-date overview of the diagnosis and treatment of neonatal malignant disorders. This special issue of the journal is dedicated to exploring various aspects of these complex conditions, including:

Genetic Predisposition and Neonatal Cancer


The articles in this section delve into the role of genetic predisposition in the development of neonatal cancer. By understanding the genetic factors that contribute to these disorders, healthcare professionals can better identify at-risk infants and implement early screening and preventive measures.

Infant Leukemias


This section provides a detailed examination of infant leukemias, including their classification, diagnosis, and treatment options. The authors discuss the latest advancements in leukemia research, including targeted therapies and immunotherapies, and their potential impact on improving outcomes for infants with this disease.

Neonatal Malignant Disorders: Brain Tumors


The articles in this section focus on the diagnosis and treatment of brain tumors in neonates. The authors discuss the various types of brain tumors, their symptoms, and the most effective treatment modalities, including surgery, radiation therapy, and chemotherapy.

Retinoblastoma


Retinoblastoma is a rare and aggressive form of eye cancer that affects infants. The articles in this section provide an in-depth analysis of retinoblastoma, including its diagnosis, treatment options, and the importance of early detection and intervention.

Neonatal Malignant Disorders: Kidney Tumors


Kidney tumors are a significant cause of morbidity and mortality in neonates. The articles in this section explore the various types of kidney tumors, their symptoms, and the most effective treatment modalities, including surgery, radiation therapy, and chemotherapy.

Neonatal Malignant Disorders: Liver Tumors


Liver tumors are another common type of neonatal malignant disorder. The articles in this section provide an overview of liver tumors, including their diagnosis, treatment options, and the importance of early detection and intervention.

Neuroblastoma


Neuroblastoma is a rare and aggressive pediatric cancer that typically affects the nervous system. The articles in this section discuss the diagnosis, treatment, and long-term outcomes of neuroblastoma, including the use of novel therapies and immunotherapies.

Neonatal Malignant Disorders: Sarcoma


Sarcoma is a diverse group of tumors that originate in connective tissues. The articles in this section explore the diagnosis, treatment, and long-term outcomes of sarcoma, including the use of targeted therapies and immunotherapies.

Neonatal Malignant Disorders: Germ Cell Tumors


Germ cell tumors are rare and complex tumors that originate in the reproductive organs. The articles in this section provide an overview of germ cell tumors, including their diagnosis, treatment, and the importance of genetic counseling for affected infants and their families.

Neonatal Histiocytoses


Neonatal histiocytoses are a group of rare tumors that affect the immune system. The articles in this section discuss the diagnosis, treatment, and long-term outcomes of neonatal histiocytoses, including the use of novel therapies and immunotherapies.

Lymphatic Malformations


Lymphatic malformations are a group of congenital disorders that affect the lymphatic system. The articles in this section explore the diagnosis, treatment, and long-term outcomes of lymphatic malformations, including the use of surgical interventions and medical management.

Long-Term Outcomes in Neonatal Cancer Survivors


The articles in this section focus on the long-term outcomes of infants with neonatal cancer. The authors discuss the challenges faced by these survivors, including the impact of treatment on their physical and psychological well-being, and the importance of supportive care and rehabilitation.
By reading this special issue, healthcare professionals and researchers will gain valuable insights into the latest developments in the diagnosis and treatment of neonatal malignant disorders. The information provided in these articles will empower readers to improve outcomes for infants with these complex conditions and contribute to the advancement of neonatal cancer research.

Expert Insights on Neonatal Malignant Disorders


In a collaborative effort with Consulting Editor, Dr. Lucky Jain, Guest Editor Dr. Daniel Wechsler has brought together a team of esteemed expert authors to deliver a comprehensive and up-to-date overview of the diagnosis and treatment of neonatal malignant disorders. This special issue of the journal is dedicated to exploring various aspects of these complex conditions, including:

Genetic Predisposition and Neonatal Cancer


The articles in this section delve into the role of genetic predisposition in the development of neonatal cancer. By understanding the genetic factors that contribute to these disorders, healthcare professionals can better identify at-risk infants and implement early screening and preventive measures.

Infant Leukemias


This section provides a detailed examination of infant leukemias, including their classification, diagnosis, and treatment options. The authors discuss the latest advancements in leukemia research, including targeted therapies and immunotherapies, and their potential impact on improving outcomes for infants with this disease.

Neonatal Malignant Disorders: Brain Tumors


The articles in this section focus on the diagnosis and treatment of brain tumors in neonates. The authors discuss the various types of brain tumors, their symptoms, and the most effective treatment modalities, including surgery, radiation therapy, and chemotherapy.

Retinoblastoma


Retinoblastoma is a rare and aggressive form of eye cancer that affects infants. The articles in this section provide an in-depth analysis of retinoblastoma, including its diagnosis, treatment options, and the importance of early detection and intervention.

Neonatal Malignant Disorders: Kidney Tumors


Kidney tumors are a significant cause of morbidity and mortality in neonates. The articles in this section explore the various types of kidney tumors, their symptoms, and the most effective treatment modalities, including surgery, radiation therapy, and chemotherapy.

Neonatal Malignant Disorders: Liver Tumors


Liver tumors are another common type of neonatal malignant disorder. The articles in this section provide an overview of liver tumors, including their diagnosis, treatment options, and the importance of early detection and intervention.

Neuroblastoma


Neuroblastoma is a rare and aggressive pediatric cancer that typically affects the nervous system. The articles in this section discuss the diagnosis, treatment, and long-term outcomes of neuroblastoma, including the use of novel therapies and immunotherapies.

Neonatal Malignant Disorders: Sarcoma


Sarcoma is a diverse group of tumors that originate in connective tissues. The articles in this section explore the diagnosis, treatment, and long-term outcomes of sarcoma, including the use of targeted therapies and immunotherapies.

Neonatal Malignant Disorders: Germ Cell Tumors


Germ cell tumors are rare and complex tumors that originate in the reproductive organs. The articles in this section provide an overview of germ cell tumors, including their diagnosis, treatment, and the importance of genetic counseling for affected infants and their families.

Neonatal Histiocytoses


Neonatal histiocytoses are a group of rare tumors that affect the immune system. The articles in this section discuss the diagnosis, treatment, and long-term outcomes of neonatal histiocytoses, including the use of novel therapies and immunotherapies.

Lymphatic Malformations


Lymphatic malformations are a group of congenital disorders that affect the lymphatic system. The articles in this section explore the diagnosis, treatment, and long-term outcomes of lymphatic malformations, including the use of surgical interventions and medical management.

Long-Term Outcomes in Neonatal Cancer Survivors


The articles in this section focus on the long-term outcomes of infants with neonatal cancer. The authors discuss the challenges faced by these survivors, including the impact of treatment on their physical and psychological well-being, and the importance of supportive care and rehabilitation.
By reading this special issue, healthcare professionals and researchers will gain valuable insights into the latest developments in the diagnosis and treatment of neonatal malignant disorders. The information provided in these articles will empower readers to improve outcomes for infants with these complex conditions and contribute to the advancement of neonatal cancer research.

Weight: 508g
Dimension: 160 x 237 x 18 (mm)
ISBN-13: 9780323761666

UK and International shipping information

UK Delivery and returns information:

  • Delivery within 2 - 3 days when ordering in the UK.
  • Shipping fee for UK customers from £2.39. Fully tracked shipping service available.
  • Returns policy: Return within 30 days of receipt for full refund.

International deliveries:

Shulph Ink now ships to Australia, Canada, France, Ireland, Italy, Germany, Spain, Netherlands, New Zealand and the United States of America.

  • Delivery times: within 5 - 20 business days when ordering to France, Germany, Ireland, Spain, Canada and the United States. Up to 30 business days for Australia and New Zealand.
  • Shipping fee: charges vary for overseas orders. Only tracked services are available for international orders.
  • Customs charges: If ordering to addresses outside the United Kingdom, you may or may not incur additional customs and duties fees during local delivery.
View full details